Clinical Trial: A Study Comparing the Effectiveness and Safety of Cenobamate When Used as the First Add-On Medication or Added After Other Medications in People with Focal Epilepsy (China)

China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study Comparing the Effectiveness and Safety of Cenobamate When Used as the First Add-On Medication or Added After Other Medications in People with Focal Epilepsy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133058

Registration Time: 2026/09/21

Type: Observational study

Primary Sponsor: Shandong Provincial Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343659

Published by HT Digital Content Services with permission from Health Daily Digest....